Vaccination against influenza, why, for whom and with which vaccine?;Influensavaksinering - Hvorfor, for hvem og med hvilken vaksine?

Tidsskrift for den Norske Laegeforening

Volumn 126, Issue 21, 2006, Pages 2814-2817

  Bergsaker, Marianne ^a   Hungnes, Olav ^a   Iversen, Bjørn ^a  

^a NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

DRUG EFFICACY; GUILLAIN BARRE SYNDROME; HEALTH CARE PERSONNEL; HUMAN; IMMUNE RESPONSE; INFECTION RISK; INFLUENZA; INFLUENZA VACCINATION; NEUROLOGIC DISEASE; PATIENT MONITORING; PNEUMONIA; REVIEW;

ADULT; AGED; CHILD; DISEASE OUTBREAKS; HEALTH EDUCATION; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; MASS IMMUNIZATION; NORWAY; RISK ASSESSMENT; SEASONS; VACCINATION;

EID: 33750716012     PISSN: 00292001     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (34)

1. Linde A, Ekdahl K, Lindbäck J et al. Aktuellt om influensa och RS i Sverige. Smittskydd 1999; 5: 110-11.
2. Smittevernhåndbok for kommunehelsetjenesten. 3. utgave. Oslo: Nasjonalt folkehelseinstitutt, 2003.
3. Alexander DJ. Avian influenza viruses and human health. I: OIE/FAO International Scientific Conference on Avian Influenza, Basel. Dev Biol 2006: 124: 77-84.
4. Brown IH. The epidemiology and evolution of influenza viruses in pigs. Vet Microbiol 2000; 74: 29-46.
5. www.who.int/csr/disease/avian_influenza/country/cases_table_2006_09_08/ en/index.html (14.9.2006).
6. Potter CW. Chronicle of influenza pandemics. I: Nicholson KG, Webster RG, Hay AJ, red. Textbook of influenza. Oxford: Blackwell Science, 1998.
7. Kawaoka Y, Krauss S, Webster RG. Avian-to-human transmission of the PB1 gene of influenza A viruses in the 1957 and 1968 pandemics. J Virol 1989; 63: 4603-8.
8. Taubenberger JK, Reid AH, Lourens RM et al. Characterization of the 1918 influenza virus polymerase genes. Nature 2005; 437: 889-93.
9. Schonberger LB, Bergman DJ, Sullivan-Bolyai SZ et al. Guillain-Barre syndrome following vaccination in the national influenza immunization program, United States, 1976-1977. Am J Epidemiol 1979; 110: 105-23.
10. Lasky T, Terraciano GJ, Magder L et al. The Guillain-Barré syndrome and the 1992-1993 and the 1993-1994 influenza vaccines. N Engl J Med 1998; 339: 1797-802.
11. WHO. The Weekly Epidemiological Record 2002; 77: 230-40.
12. Gross PA, Hermogenes AW, Sacks HS et al. The efficacy of influenza vaccine in elderly persons. A meta-analysis and review of the literature. Ann Intern Med 1995; 123: 518-27.
13. Nichol KL, Nordin J, Mullooly J et al. Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly. N Engl J Med 2003; 348: 1322-32.
14. Hedlund J, Christenson B, Lundbergh P et al. Effects of a large-scale intervention with influenzae and 23-valent pneumococcal vaccines in elderly people: a 1-year follow-up. Vaccine 2003; 21: 3906-11.
15. Christenson B, Hedlund J, Lundgren P et al. Additive preventive effect of influenza and pneumococcal vaccines in elderly persons. Eur Respir J 2004; 23: 363-8.
16. Jefferson T, Rivetti D, Rivetti A et al. Efficacy and effectiveness of influenza vaccines in elderly people: a systematic review. Lancet 2005; 366: 1165-74.
17. Vu T, Farish S, Jenkins M et al. A meta-analysis of effectiveness of influenza vaccine in persons aged 65 years and over living in the community. Vaccine 2002; 20: 1831-6.
18. Demicheli V, Rivetti D, Deeks JJ et al. Vaccines for preventing influenza in healthy adults (review). Cochrane Database Syst Rev 2004: CD001269.
19. Tacken MA, Braspenning JC, Berende A et al. Vaccination of high-risk patients against influenza: impact on primary care contact rates during epidemics. Analysis of routinely collected data. Vaccine 2004; 22: 2985-92.
20. Voordouw AC, Sturkenboom MC, Dieleman JP et al. Annual revaccination against influenza and mortality risk in community-dwelling elderly persons. JAMA 2004; 292: 2089-95.
21. Kohut ML, Arntson BA, Lee W et al. Moderate exercise improves antibody response to influenza immunization in older adults. Vaccine 2004; 22: 2298-306.
22. Hak E, van Essen GA, Stalman WA et al. Improving influenza vaccination coverage among high-risk patients: a role for computer-supported prevention strategy? Fam Pract 1998; 2: 138-43.
23. Macroepidemiology of Influenza Vaccination (MIV) Study Group. The macro-epidemiology of influenza vaccination in 56 countries, 1997-2003. Vaccine 2005; 23: 5133-43.
24. Dannetun E, Tegnell A, Normann B et al. Influenza vaccine coverage and reasons for non-vaccination in a sample of people above 65 years of age, in Sweden, 1998-2000. Scand J Infect Dis 2003; 35: 389-93.
25. Kroneman M, van Essen GA, Paget JW. Influenza vaccination coverage and reasons to refrain among high-risk persons in four European countries. Vaccine 2006; 24: 622-8.
26. Hak E, Hermens RP, Hoes AW et al. Effectiveness of a co-ordinated nation-wide programme to improve influenza immunisation rates in The Netherlands. Scand J Prim Health Care 2000; 18: 237-41.
27. Hofmann F, Ferracin C, Marsh G et al. Influenza vaccination of healthcare workers: a literature review of attitudes and beliefs. Infection 2006; 34: 142-7.
28. Elder AG, O'Donnell B, McCruden EA et al. Incidence and recall of influenza in a cohort of Glasgow healthcare workers during the 1993-4 epidemic: results of serum testing and questionnaire. BMJ 1996; 313: 1241-2.
29. Yassi A, Kettner J, Hammond G et al. Effectiveness and cost-benefit of an influenza vaccination program for health care workers. Can J Infect Dis 1991; 2: 101-8.
30. Wilde JA, McMillan JA, Serwint J et al. Effectiveness of influenza vaccine in health care professionals: a randomized trial. JAMA 1999; 281: 908-13.
31. Reichert TA, Sugaya N, Fedson DS et al. Japanese experience with vaccinating schoolchildren against influenza. N Engl J Med 2001; 344: 889-96.
32. Thomas RE, Jefferson TO, Demicheli V et al. Influenza vaccination for health-care workers who work with elderly people in institutions: a systematic review. Lancet Infect Dis 2006; 6: 273-9.
33. World Health Organization. Assessing the pandemic threat. www.who.int/csr/disease/influenza/WHO_CDS_2005_29/en/index.html (16.8.2006).
34. Nasjonal beredskapsplan for pandemisk influensa. Versjon 3.0. Oslo: Helse- og omsorgsdepartementet, 2006.